The findings come from Sweden's Mammography Screening with Artificial Intelligence, or MASAI, a randomized clinical trial incorporating over 105,000 women.
The rad was accused of writing a “confusing” report that allegedly had long-lasting implications for the plaintiff's child, who was born with severe birth defects.
The federal government recently released new data pertaining to the landmark legislation, meant to protect patients from receiving unexpected medical bills.
As radiology departments across the US continue to navigate the complexities of the current imaging market, including disruptions in supply chains and increased demand for CT contrast media, one constant remains: the need for reliable, quality supply partners to help sustain patient care.
Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.
